Portsmouth and South East Hampshire
Prescribing Formulary
 
back
6 Endocrine system
06-01-02-03 Other antidiabetic drugs

Alogliptin Vipidia▼®
First Choice

First choice DPP-4 inhibitor for new initiations


Green View adult BNF  View SPC online  View childrens BNF
Acarbose Glucobay®
Formulary

Green View adult BNF  View SPC online  View childrens BNF
Canagliflozin Invokana▼®
Formulary
Link  NICE TA315: Canagliflozin for type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
 

Green View adult BNF  View SPC online  View childrens BNF
Dapagliflozin Forxiga▼®
Formulary

Green For use in type 2 diabetics

 

Red For use in type 1 diabetics

Link  NICE TA 418 Dapagliflozin in triple therapy for treating type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
Link  NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes
Link  NICE TA597: Dapagliflozin with insulin for treating type 1 diabetes
 

View adult BNF  View SPC online  View childrens BNF
Dapagliflozin Forxiga▼®
Formulary

Amber recommended for treating symptomatic chronic heart failure with reduced ejection fraction in adults as an add on to optimised standard care, as per NICE TA 679

Link  NICE TA 679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction
 

Amber Recommended View adult BNF  View SPC online  View childrens BNF
Dulaglutide
Formulary

For type 2 diabetes


Green View adult BNF  View SPC online  View childrens BNF
Empagliflozin Jardiance▼®
Formulary
Link  NICE TA336: Empagliflozin for type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
 

Green View adult BNF  View SPC online  View childrens BNF
Ertugliflozin Steglatro®
Formulary
Link  NICE TA 572: Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
Link  NICE TA 583: Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
 

Green View adult BNF  View SPC online  View childrens BNF
Exenatide Byetta▼®
Formulary

Twice daily injection - type 2 diabetes


Green View adult BNF  View SPC online  View childrens BNF
Exenatide prolonged release Bydureon▼®
Formulary

Once weekly injection for type 2 diabetes

Link  NICE NG 28: Type 2 diabetes in adults: management
 

Green View adult BNF  View SPC online  View childrens BNF
Linagliptin Trajenta▼®
Formulary

Green View adult BNF  View SPC online  View childrens BNF
Liraglutide Saxenda®
Formulary

(only Saxenda® brand): Weight management in adults according to NICE TA664

Link  NICE TA 664 Liraglutide for managing overweight and obesity
 

Red View adult BNF  View SPC online  View childrens BNF
Liraglutide Victoza®
Formulary

Once daily injection for type 2 diabetes


Green View adult BNF  View SPC online  View childrens BNF
Pioglitazone Actos®
Formulary

Green View adult BNF  View SPC online  View childrens BNF
Pioglitazone and Metfomin Competact®
Formulary

For patients established on both agents


Green View adult BNF  View SPC online  View childrens BNF
Repaglinide Prandin®
Formulary

Secondary Care initiated

 

Alternative to sulphonylurea in selected patients


Amber Initiation View adult BNF  View SPC online  View childrens BNF
Semaglutide Ozempic®
Formulary

Once weekly injection for type 2 diabetes


Green View adult BNF  View SPC online  View childrens BNF
Sitagliptin Januvia®
Formulary

 


 


Green View adult BNF  View SPC online  View childrens BNF
Semaglutide Rybelsus®
Formulary

For restricted use for patients where subcutaneous semaglutide would be considered an option but where the subcutaneous rote of administration is not tolerated or advisable

May be initiated on the advice of community specialist nurses.


Amber Recommended View adult BNF  View SPC online  View childrens BNF
Albiglutide Eperzan®
Non Formulary

Will be discontinued from commercial sale worldwide in July 2018. This withdrawal is on commercial grounds only and not related to safety or efficacy of the medicine. Albiglutide is not on the formulary, but may be encountered when treating out-of-area patients.


 


View adult BNF  View SPC online  View childrens BNF
Alogliptin / metformin Vipdomet®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Alogliptin / pioglitazone Incresync®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Canagliflozin / metformin IR Vokanamet®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Dapagliflozin / metformin Xigduo®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Empagliflozin + linagliptin Glyxambi®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Empagliflozin and Metformin Synjardy®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Linagliptin/ metformin Jentadueto®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Lixisenatide Lyxumia▼®
Non Formulary

Once daily injection for type 2 diabetes


View adult BNF  View SPC online  View childrens BNF
Nateglinide Starlix®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Saxagliptin Onglyza®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Saxagliptin and metformin Komboglyze®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Sitagliptin and Metformin Janumet®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Vildagliptin
Non Formulary

View adult BNF  View SPC online  View childrens BNF